High levels of
antibodies (Abs) against the C-terminal end of the Trypanosoma cruzi ribosomal P2β
protein, defined by the R13
peptide, are detected in sera from patients with chronic Chagas
heart disease (cChHD). These Abs can cross-react with the β1-adrenergic receptor (β1-AR), inducing a functional response in cardiomyocytes. In this study, we report that a monoclonal Ab against the R13
peptide, called mAb 17.2, and its
single-chain Fv fragment (scFv), C5, caused apoptosis of murine adult cardiac HL-1 cells, and this effect was inhibited by pre-incubation with the β-blocker,
propranolol. In addition, apoptosis induced by mAb 17.2 might involve the mitochondrial pathway evidenced by an increase in pro-apoptotic molecule, Bax/anti-apoptotic molecule, Bcl(XL),
mRNA levels. HL-1 cells also underwent apoptosis after incubation with nine of 23 IgGs from cChHD patients (39.1%) that presented reactivity against R13
peptide and β1-AR. The apoptotic effect caused by these IgGs was partially abolished by pre-incubation with R13
peptide or
propranolol, suggesting the involvement of the C-terminal end of ribosomal P
proteins and the β-
adrenergic pathway. Moreover, we observed high rates of cardiomyocyte apoptosis in two tissue samples from cChHD patients by using a TUNEL assay and staining of active
caspase-3. Our data demonstrate that Abs developed during T. cruzi
infection have a strong cardiomyocyte apoptosis inducing ability, which could contribute to the
heart disease developed in patients with cChHD.